Two-year observational study of deferiprone in superficial siderosis

  • Version 12.2017
  • Download 320
  • File Size 633.45 KB
  • File Count 1
  • Create Date January 3, 2018
  • Last Updated November 3, 2020

Two-year observational study of deferiprone in superficial siderosis

INTRODUCTION:

Superficial siderosis is a rare, neurodegenerative disease caused by toxic accumulation of hemosiderin on the surface of the brain and the spinal cord, most commonly from chronic subarachnoid hemorrhage.

AIMS:

The aim of this study was to assess the clinical and radiological outcomes of superficial siderosis patients using deferiprone, a cell permeant iron chelator. Subjects obtained pre- and post-treatment brain MRIs and weekly laboratory tests. Osirix software was used to develop a method of quantifying hemosiderin deposition. Three-dimensional whole brain images of gradient echo images were rendered and compared by dividing the mean T2 hyperintensity to the maximal cerebrospinal fluid signal.

About Living With Superficial Siderosis

Living with Superficial Siderosis is the informational

Comments are closed.